Results 281 to 290 of about 350,390 (302)
Some of the next articles are maybe not open access.
Phytotherapic Drugs for COVID-19 Treatment: A Scoping Review
Current Pharmaceutical Design, 2021Background: The rapid eruption of Coronavirus at the end of 2019 has caused global health crisis and significant loss to the economy and social well-being. This created a massive shortage of advanced health facilities with inadequate medicinal supply, further deteriorating human health conditions.
Meenakshi, Singh +5 more
openaire +2 more sources
COVID-19 drug discovery and treatment options
Nature Reviews MicrobiologyThe coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused substantial morbidity and mortality, and serious social and economic disruptions worldwide. Unvaccinated or incompletely vaccinated older individuals with underlying diseases are especially prone to severe disease.
Jasper Fuk-Woo Chan +4 more
openaire +2 more sources
A review on drug repurposing applicable to COVID-19
Briefings in Bioinformatics, 2021Serena Dotolo +2 more
exaly
Identification of Drug Interaction Adverse Events in Patients With COVID-19
JAMA Network Open, 2022Valeria Conti +2 more
exaly
Disease-drug and drug-drug interaction in COVID-19: Risk and assessment
Biomedicine and Pharmacotherapy, 2021Devendra Kumar, Neerja Trivedi
exaly
Computational drug discovery and repurposing for the treatment of COVID-19: A systematic review
Bioorganic Chemistry, 2021Niloufar Yazdanpanah +2 more
exaly
Considerations for Drug Interactions on QTc in Exploratory COVID-19 Treatment
Circulation, 2020Dan M Roden +2 more
exaly